Oxidative stress imbalance n Pulmonary&Cardiovascular disease,Electron paramagnet

肺氧化应激失衡

基本信息

  • 批准号:
    8052669
  • 负责人:
  • 金额:
    $ 25.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-02 至 2012-04-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall objective of this research effort is to identify the causes and consequences of nitric oxide and oxidant production imbalances in health and disease, investigate mechanisms of microbial killing by the immune system, study metal homeostasis in cells and how it contributes to cellular proliferation and migration and establish the relevance of redox processes in the differentiation of stem cells. It is currently well-established that oxidant homeostasis and electron transfer reactions are fundamental in maintaining physiological processes in health and that their impairment or dysfunction cause severe phenotypical consequences. Both reduced oxidant bioavailability or overproduction and difficulties in mediating key electron transfer reactions are key factors leading to the impairment of beneficial signal transduction events or inducers of cellular and tissue damage. Oxidant imbalances are becoming recognized contributors of hypertension and cardiovascular complications in diabetes, atherosclerosis, inflammation, male impotence, and important factors contributing to stem cell differentiation and regeneration and cancer onset, progression and prognosis. All of these are human conditions of public health interest. The University of Illinois at Chicago Colleges of Medicine, Dentistry, Pharmacy and Biological Sciences through its diverse departments and research initiatives is currently developing multiple studies and programs dedicated to the understanding of how paramagnetic species that can be tracked, identified and quantified through the use of EPR lead to increased lung permeability in inflammation and sepsis, oxidative stress induced alterations of ventricular function, oxidant mediated vascular remodeling and damage, stem cell differentiation, protein interactions, cancer biology, photosynthesis, microbial killing and drug metabolism. The development of such initiatives depend, at least in part, on our ability to identify which among the many reactive oxygen and nitrogen species are produced at different stages of disease progression, and the precise quantification of reactive species yield, on our capacity to define electron donors and acceptors and track molecular events influencing membrane permeability and interaction with drugs. Electron paramagnetic resonance (EPR) remains the only available technique capable of unequivocally identifying particular paramagnetic species (stable and short lived) based on fingerprint signature resonance spectra and serves the purpose of quantifying the generation of free radical oxidants. For example, it is of pivotal importance to directly identify the sources of superoxide radical anion and nitric oxide that contribute to tissue damage in inflammation and trigger signaling events that contribute to pulmonary edema, hypertension and cardiac failure or trigger events such as stem cell differentiation. At the same time it would be possible to determine how superoxide dismutase enzymes contribute to avoid or promote oxidative stress events warranting or compromising nitric oxide bioavailability. Through spin labeling it would be possible to study membrane microdomain formation and track drug metabolites. Therefore, the acquisition of an EPR instrument would integrate and uniquely contribute for the development of the current initiatives while fostering new collaborative studies putting the departments in the position of making important progress towards the understanding of intricate molecular processes and the development of therapies to re-equilibrate physiological processes at the cellular level.
描述(由申请人提供):这项研究工作的总体目标是确定健康和疾病中一氧化氮和氧化剂产生不平衡的原因和后果,研究免疫系统杀死微生物的机制,研究细胞中的金属稳态以及如何它有助于细胞增殖和迁移,并建立氧化还原过程在干细胞分化中的相关性。目前已明确,氧化剂稳态和电子转移反应是维持健康生理过程的基础,它们的损伤或功能障碍会导致严重的表型后果。氧化剂生物利用度的降低或过量产生以及介导关键电子转移反应的困难都是导致有益信号转导事件或细胞和组织损伤诱导物受损的关键因素。氧化失衡已成为公认的高血压和糖尿病心血管并发症、动脉粥样硬化、炎症、男性阳痿的促成因素,也是促进干细胞分化和再生以及癌症发生、进展和预后的重要因素。所有这些都是涉及公共卫生利益的人类状况。伊利诺伊大学芝加哥分校医学院、牙科学院、药学学院和生物科学学院通过其不同的院系和研究计划目前正在开展多项研究和项目,致力于了解如何通过使用EPR 导致炎症和脓毒症中肺通透性增加、氧化应激诱导的心室功能改变、氧化剂介导的血管重塑和损伤、干细胞分化、蛋白质相互作用、癌症生物学、光合作用、微生物杀灭和药物新陈代谢。这些举措的发展至少部分取决于我们确定在疾病进展的不同阶段产生的许多活性氧和氮物种的能力,以及活性物种产量的精确量化,取决于我们定义电子的能力供体和受体并跟踪影响膜通透性和与药物相互作用的分子事件。电子顺磁共振 (EPR) 仍然是唯一能够根据指纹特征共振光谱明确识别特定顺磁性物质(稳定和短命)的可用技术,并用于量化自由基氧化剂的生成。例如,直接识别超氧自由基阴离子和一氧化氮的来源至关重要,它们会导致炎症中的组织损伤,并触发导致肺水肿、高血压和心力衰竭的信号事件或触发干细胞分化等事件。同时,可以确定超氧化物歧化酶如何有助于避免或促进保证或损害一氧化氮生物利用度的氧化应激事件。通过自旋标记,可以研究膜微区的形成并追踪药物代谢物。因此,购买 EPR 仪器将整合并独特地促进当前举措的发展,同时促进新的合作研究,使各部门在理解复杂的分子过程和开发治疗方法方面取得重要进展。在细胞水平上平衡生理过程。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marcelo G Bonini其他文献

Histone oxidation as a new mechanism of metabolic control over gene expression.
组蛋白氧化作为基因表达代谢控制的新机制。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Benjamin N Gantner;Flavio R. Palma;Cezar Kayzuka;Riccardo Lacchini;Daniel R Foltz;Vadim Backman;Neil Kelleher;A. Shilatifard;Marcelo G Bonini
  • 通讯作者:
    Marcelo G Bonini
Lessons learned in the practice of community-based participatory research with community partner collaboration in study design and implementation: the community scientist model
在研究设计和实施中与社区伙伴合作进行基于社区的参与性研究实践中吸取的经验教训:社区科学家模型
  • DOI:
    10.1007/s10552-023-01699-7
  • 发表时间:
    2023-04-21
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Megan A Morrell;Tabitha R Willis;Denisha R. Brown;Catherine O’Brian;Sharon L Post;G. Woloschak;Marcelo G Bonini;T. Paunesku;J. Popović;Tarneka Manning;Candace Henley;J. Girotti;R. Rogers;Carmen Velásquez;José López;Joanne Glenn;Melissa Simon
  • 通讯作者:
    Melissa Simon
Nitric oxide cell signaling: S-nitrosation of Ras superfamily GTPases.
一氧化氮细胞信号传导:Ras 超家族 GTP 酶的 S-亚硝化。
  • DOI:
    10.1016/j.cardiores.2007.04.013
  • 发表时间:
    2007-07-15
  • 期刊:
  • 影响因子:
    10.8
  • 作者:
    Kimberly W Raines;Marcelo G Bonini;Sharon L Campbell
  • 通讯作者:
    Sharon L Campbell
Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance
组蛋白 H3.1 是一种染色质嵌入的氧化还原传感器,由肿瘤细胞触发,形成适应性表型可塑性和多药耐药性
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Flavio R Palma;Diego R Coelho;K. Pulakanti;Marcelo J Sakiyama;Yunping Huang;Fernando T Ogata;Jeanne M. Danes;Alison Meyer;Cristina M Furdui;Doug Spitz;Ana P. Gomes;Benjamin N Gantner;Sridhar Rao;Vadim Backman;Marcelo G Bonini
  • 通讯作者:
    Marcelo G Bonini
ROS production by mitochondria: function or dysfunction?
线粒体产生 ROS:功能还是功能障碍?
  • DOI:
    10.1038/s41388-023-02907-z
  • 发表时间:
    2023-12-11
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Flavio R. Palma;Benjamin N Gantner;Marcelo J. Sakiyama;Cezar Kayzuka;Sanjeev Shukla;Riccardo Lacchini;Brian Cunniff;Marcelo G Bonini
  • 通讯作者:
    Marcelo G Bonini

Marcelo G Bonini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marcelo G Bonini', 18)}}的其他基金

A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
巨噬细胞核中的氧化还原敏感开关调节急性期炎症损伤
  • 批准号:
    10631088
  • 财政年份:
    2022
  • 资助金额:
    $ 25.1万
  • 项目类别:
A redox-sensitive switch in the macrophage nucleus regulates acute phase inflammatory injury
巨噬细胞核中的氧化还原敏感开关调节急性期炎症损伤
  • 批准号:
    10451112
  • 财政年份:
    2022
  • 资助金额:
    $ 25.1万
  • 项目类别:
Arsenic suppresses progesterone receptor signaling and promotes tamoxifen resistance and metastasis of ER+ breast cancer
砷抑制孕激素受体信号传导并促进 ER 乳腺癌的他莫昔芬耐药性和转移
  • 批准号:
    10662054
  • 财政年份:
    2022
  • 资助金额:
    $ 25.1万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10488608
  • 财政年份:
    2020
  • 资助金额:
    $ 25.1万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10204605
  • 财政年份:
    2020
  • 资助金额:
    $ 25.1万
  • 项目类别:
Environmental Arsenic in the Subtype Specification of Breast Cancer
乳腺癌亚型规范中的环境砷
  • 批准号:
    10252934
  • 财政年份:
    2020
  • 资助金额:
    $ 25.1万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10193167
  • 财政年份:
    2018
  • 资助金额:
    $ 25.1万
  • 项目类别:
MnSOD Acetylation Promotes Cancer Stem Cell Phenotypes in Breast Cancer
MnSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    9763487
  • 财政年份:
    2018
  • 资助金额:
    $ 25.1万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10221632
  • 财政年份:
    2018
  • 资助金额:
    $ 25.1万
  • 项目类别:
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCER
MNSOD 乙酰化促进乳腺癌干细胞表型
  • 批准号:
    10453720
  • 财政年份:
    2018
  • 资助金额:
    $ 25.1万
  • 项目类别:

相似国自然基金

Kallistatin抑制管周脂肪细胞线粒体裂变拮抗动脉粥样硬化的作用及机制研究
  • 批准号:
    82370443
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
蛋白激酶D(PKD)抑制剂CRT0066101通过囊泡转运蛋白/TGN/NLRP3途径抗动脉粥样硬化炎症的作用及机制
  • 批准号:
    82304489
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
NPTX1促进血管内皮细胞衰老在动脉粥样硬化中的作用机制及临床价值研究
  • 批准号:
    82372302
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SAH水解酶缺乏通过表观遗传调控KLF4促进动脉粥样硬化易损斑块形成的作用机制研究
  • 批准号:
    82373553
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
二肽基肽酶在免疫-菌群失衡促动脉粥样硬化中的作用及机制研究
  • 批准号:
    82370465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
  • 批准号:
    10662850
  • 财政年份:
    2023
  • 资助金额:
    $ 25.1万
  • 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
  • 批准号:
    10603408
  • 财政年份:
    2023
  • 资助金额:
    $ 25.1万
  • 项目类别:
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
  • 批准号:
    10662850
  • 财政年份:
    2023
  • 资助金额:
    $ 25.1万
  • 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
  • 批准号:
    10901520
  • 财政年份:
    2023
  • 资助金额:
    $ 25.1万
  • 项目类别:
Novel Coronary Artery Vasodilator Development
新型冠状动脉血管扩张剂的开发
  • 批准号:
    10758940
  • 财政年份:
    2023
  • 资助金额:
    $ 25.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了